DSM-Firmenich Divests Stake in Robertet S.A.

Deal News | Nov 21, 2024 | PR Newswire Cision dsm-firmenich

DSM-Firmenich AG has sold its entire stake in Robertet S.A., comprising 24,408 ordinary shares or approximately 1% of Robertet’s share capital, to a long-term, non-institutional investor. The sale was facilitated through a bilateral agreement that includes a 60-day lockup period for the purchaser. This transaction marks DSM-Firmenich’s complete exit from its investment in Robertet. DSM-Firmenich is a prominent Swiss-Dutch company specializing in innovating and manufacturing nutrition, health, and beauty products. It operates in nearly 60 countries, generating revenues exceeding €12 billion, supported by a workforce of nearly 30,000 employees. This divestment is part of DSM-Firmenich’s strategy to refine its investment portfolio and focus on core areas of business that drive sustainability and innovation.

Sectors

  • Chemicals
  • Fragrances and Flavors

Geography

  • Switzerland – DSM-Firmenich AG is headquartered in Switzerland.
  • Netherlands – DSM-Firmenich AG is a Swiss-Dutch company with significant operations in the Netherlands.
  • France – Robertet S.A., the company in which DSM-Firmenich held shares, is based in France.

Industry

  • Chemicals – The transaction involves DSM-Firmenich AG, a company engaged in the chemicals industry, particularly in nutrition and health products.
  • Fragrances and Flavors – Robertet S.A., the target company whose shares were sold, operates within the fragrances and flavors industry.

Financials

  • 24,408 shares – The number of Robertet S.A. ordinary shares sold by DSM-Firmenich AG.
  • c. 1% – The percentage of Robertet S.A.'s share capital represented by the shares sold.

Participants

NameRoleTypeDescription
DSM-Firmenich AGSellerCompanyA Swiss-Dutch global company operating in nutrition, health, and beauty with revenues of over €12 billion.
Robertet S.A.TargetCompanyA French company specializing in natural fragrances and flavors.
Non-Institutional InvestorBuyerCompanyThe buyer of the shares who agreed on a 60-day lockup period.